Effectiveness of a Transdiagnostic Guided Internet-Delivered Protocol for Emotional Disorders Versus Treatment as Usual in Specialized Care: Randomized Controlled Trial.
anxiety
cognitive behavioral therapy
depression
emotional disorders
internet
specialized care
transdiagnostic
Journal
Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882
Informations de publication
Date de publication:
07 07 2020
07 07 2020
Historique:
received:
14
02
2020
accepted:
08
04
2020
revised:
08
04
2020
entrez:
17
7
2020
pubmed:
17
7
2020
medline:
9
1
2021
Statut:
epublish
Résumé
Anxiety disorders and depression (emotional disorders) are highly prevalent mental disorders. Extensive empirical evidence supports the efficacy of cognitive behavioral therapy (CBT) for the treatment of these disorders. However, there are still some barriers related to their dissemination and implementation, which make it difficult for patients to receive these treatments, especially in public health care settings where resources are limited. Recent advances in improving CBT dissemination encompass different perspectives. One is the transdiagnostic approach, which offers treatment protocols that can be used for a range of emotional disorders. Another approach is the use of the internet to reach a larger number of people who could benefit from CBT. This study aimed to analyze the effectiveness and acceptability of a transdiagnostic internet-delivered protocol (EmotionRegulation) with human and automated guidance in patients from public specialized mental health care settings. A 2-armed randomized controlled trial (RCT) was conducted to compare the effectiveness of EmotionRegulation with treatment as usual (TAU) in specialized mental health care. In all, 214 participants were randomly assigned to receive either EmotionRegulation (n=106) or TAU (n=108). Measurement assessments were conducted at pre- and postintervention and at a 3-month follow-up. The results revealed the superiority of EmotionRegulation over TAU on measures of depression (d=0.41), anxiety (d=0.35), and health-related quality of life (d=-0.45) at posttreatment, and these gains were maintained at the 3-month follow-up. Furthermore, the results for expectations and opinions showed that EmotionRegulation was well accepted by participants. EmotionRegulation was more effective than TAU for the treatment of emotional disorders in the Spanish public mental health system. The implications of this RCT, limitations, and suggestions for future research are discussed. ClinicalTrials.gov NCT02345668; https://clinicaltrials.gov/ct2/show/NCT02345668.
Sections du résumé
BACKGROUND
Anxiety disorders and depression (emotional disorders) are highly prevalent mental disorders. Extensive empirical evidence supports the efficacy of cognitive behavioral therapy (CBT) for the treatment of these disorders. However, there are still some barriers related to their dissemination and implementation, which make it difficult for patients to receive these treatments, especially in public health care settings where resources are limited. Recent advances in improving CBT dissemination encompass different perspectives. One is the transdiagnostic approach, which offers treatment protocols that can be used for a range of emotional disorders. Another approach is the use of the internet to reach a larger number of people who could benefit from CBT.
OBJECTIVE
This study aimed to analyze the effectiveness and acceptability of a transdiagnostic internet-delivered protocol (EmotionRegulation) with human and automated guidance in patients from public specialized mental health care settings.
METHODS
A 2-armed randomized controlled trial (RCT) was conducted to compare the effectiveness of EmotionRegulation with treatment as usual (TAU) in specialized mental health care. In all, 214 participants were randomly assigned to receive either EmotionRegulation (n=106) or TAU (n=108). Measurement assessments were conducted at pre- and postintervention and at a 3-month follow-up.
RESULTS
The results revealed the superiority of EmotionRegulation over TAU on measures of depression (d=0.41), anxiety (d=0.35), and health-related quality of life (d=-0.45) at posttreatment, and these gains were maintained at the 3-month follow-up. Furthermore, the results for expectations and opinions showed that EmotionRegulation was well accepted by participants.
CONCLUSIONS
EmotionRegulation was more effective than TAU for the treatment of emotional disorders in the Spanish public mental health system. The implications of this RCT, limitations, and suggestions for future research are discussed.
TRIAL REGISTRATION
ClinicalTrials.gov NCT02345668; https://clinicaltrials.gov/ct2/show/NCT02345668.
Identifiants
pubmed: 32673226
pii: v22i7e18220
doi: 10.2196/18220
pmc: PMC7381075
doi:
Banques de données
ClinicalTrials.gov
['NCT02345668']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e18220Informations de copyright
©Alberto González-Robles, Amanda Díaz-García, Azucena García-Palacios, Pablo Roca, Josep Antoni Ramos-Quiroga, Cristina Botella. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 07.07.2020.
Références
Compr Psychiatry. 2014 Nov;55(8):1920-7
pubmed: 25113056
Lancet. 2018 Nov 17;392(10160):2214-2228
pubmed: 30314860
J Clin Psychiatry. 2001;62 Suppl 11:37-42; discussion 43-5
pubmed: 11414549
Ann Intern Med. 2007 Mar 6;146(5):317-25
pubmed: 17339617
Clin Psychol Rev. 2015 Aug;40:91-110
pubmed: 26094079
Bull World Health Organ. 2004 Nov;82(11):858-66
pubmed: 15640922
Compr Psychiatry. 2014 Aug;55(6):1426-34
pubmed: 24933653
Depress Anxiety. 2010 Oct;27(10):891-932
pubmed: 20830696
Psychother Psychosom. 2013;82(4):221-33
pubmed: 23712109
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
Semergen. 2012 Sep;38(6):354-9
pubmed: 22935831
J Consult Clin Psychol. 1991 Feb;59(1):12-9
pubmed: 2002127
Behav Res Ther. 1990;28(6):487-95
pubmed: 2076086
PeerJ. 2013 Jul 09;1:e102
pubmed: 23862104
J Affect Disord. 2016 Jul 15;199:30-41
pubmed: 27060430
PLoS One. 2018 Nov 15;13(11):e0207396
pubmed: 30440020
J Behav Ther Exp Psychiatry. 2005 Jun;36(2):79-97
pubmed: 15814078
Annu Rev Clin Psychol. 2016;12:157-79
pubmed: 26652054
J Consult Psychol. 1967 Apr;31(2):109-18
pubmed: 5342732
J Med Internet Res. 2006 Jun 23;8(2):e10
pubmed: 16867965
Behav Res Ther. 2011 Aug;49(8):441-52
pubmed: 21679925
J Abnorm Psychol. 2001 Nov;110(4):585-99
pubmed: 11727948
Cogn Behav Ther. 2014;43(3):171-84
pubmed: 24646219
Behav Ther. 2017 Jan;48(1):128-138
pubmed: 28077216
BMC Med Res Methodol. 2001;1:2
pubmed: 11336663
Psychol Med. 2017 Jan;47(1):67-80
pubmed: 27655039
Psychol Med. 2014 Aug;44(11):2363-74
pubmed: 24451993
Psychol Med. 2015 Dec;45(16):3357-76
pubmed: 26235445
J Med Internet Res. 2016 Aug 26;18(8):e231
pubmed: 27565118
Trials. 2015 Oct 31;16:488
pubmed: 26519046
Depress Anxiety. 2002;15(4):183-5
pubmed: 12112724
Arch Gen Psychiatry. 2005 Jun;62(6):617-27
pubmed: 15939839
PLoS Med. 2013 Nov;10(11):e1001547
pubmed: 24223526
Neuropsychiatr Dis Treat. 2017 Mar 31;13:987-1006
pubmed: 28408833
Behav Ther. 2012 Sep;43(3):666-78
pubmed: 22697453
Clin Psychol Rev. 2015 Aug;40:156-69
pubmed: 26117062
Eur Neuropsychopharmacol. 2013 Nov;23(11):1443-51
pubmed: 23726508
J Affect Disord. 2015 Apr 1;175:152-67
pubmed: 25618002
Psychol Assess. 2002 Dec;14(4):485-96
pubmed: 12501574
JAMA. 2012 Mar 14;307(10):1033-4
pubmed: 22416097
J Anxiety Disord. 2017 Mar;46:11-24
pubmed: 27466074
J Anxiety Disord. 2005;19(8):893-903
pubmed: 16243637
Psychol Assess. 2009 Sep;21(3):256-71
pubmed: 19719339
J Affect Disord. 2005 Sep;88(1):27-45
pubmed: 16005982
Clin Psychol Rev. 2006 Oct;26(6):657-78
pubmed: 15908088
Internet Interv. 2018 Apr 06;12:181-188
pubmed: 30135782
Eur J Neurol. 2005 Jun;12 Suppl 1:39-44
pubmed: 15877777
J Anxiety Disord. 2007;21(5):603-24
pubmed: 17084589
World Psychiatry. 2014 Feb;13(1):4-11
pubmed: 24497236
Am J Psychiatry. 2005 Jun;162(6):1171-8
pubmed: 15930066
Behav Ther. 2012 Sep;43(3):506-17
pubmed: 22697440
JAMA Psychiatry. 2017 Sep 1;74(9):875-884
pubmed: 28768327
Behav Res Ther. 2010 Sep;48(9):890-9
pubmed: 20561606
Med Clin (Barc). 1999;112 Suppl 1:79-85
pubmed: 10618804
Curr Psychiatry Rep. 2010 Dec;12(6):547-52
pubmed: 20872100
PLoS One. 2010 Oct 13;5(10):e13196
pubmed: 20967242
BMJ. 2010 Mar 23;340:c869
pubmed: 20332511
J Anxiety Disord. 2015 Oct;35:88-102
pubmed: 26422822
BMC Psychiatry. 2019 Mar 6;19(1):86
pubmed: 30841930
PLoS One. 2017 Feb 27;12(2):e0172741
pubmed: 28241025
J Consult Clin Psychol. 2008 Dec;76(6):909-22
pubmed: 19045960
Neuropsychiatr Dis Treat. 2018 Mar 28;14:879-892
pubmed: 29636613
Cogn Behav Ther. 2017 Jan;46(1):1-28
pubmed: 27712544
Arch Gen Psychiatry. 2005 Jun;62(6):593-602
pubmed: 15939837
Lancet. 2007 Sep 8;370(9590):841-50
pubmed: 17826169
Lancet Psychiatry. 2014 Oct;1(5):368-76
pubmed: 26361000
Behav Modif. 2007 Nov;31(6):772-99
pubmed: 17932235
J Clin Epidemiol. 2006 Sep;59(9):920-5
pubmed: 16895814
J Anxiety Disord. 2015 Dec;36:63-77
pubmed: 26460536
J Anxiety Disord. 2008;22(1):108-16
pubmed: 17321717
Behav Res Ther. 1998 Apr;36(4):455-70
pubmed: 9670605
Behav Modif. 2019 Jan;43(1):26-55
pubmed: 29047288
Clin Psychol Rev. 2015 Dec;42:168-78
pubmed: 26431668
Br J Psychiatry. 2005 Jan;186:11-7
pubmed: 15630118
Med J Aust. 2010 Jun 7;192(S11):S4-11
pubmed: 20528707
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
J Psychiatr Res. 2018 Sep;104:211-216
pubmed: 30103069
Behav Res Ther. 2009 Nov;47(11):946-53
pubmed: 19643395
Span J Psychol. 2008 Nov;11(2):626-40
pubmed: 18988448
PLoS One. 2014 Jul 16;9(7):e100674
pubmed: 25029507
J Affect Disord. 2012 Mar;137(1-3):106-12
pubmed: 22240085
Am J Psychother. 2015;69(2):111-28
pubmed: 26160618
Behav Ther. 2016 Nov;47(6):838-853
pubmed: 27993336
J Med Internet Res. 2011 Dec 31;13(4):e126
pubmed: 22209829
J Clin Psychol. 2015 Apr;71(4):346-61
pubmed: 25534425
Clin Psychol Sci. 2019 Jan;7(1):37-50
pubmed: 30713811
Expert Rev Neurother. 2012 Jul;12(7):861-9; quiz 870
pubmed: 22853793
Br J Clin Psychol. 2010 Nov;49(Pt 4):491-505
pubmed: 19878622
Behav Res Ther. 2009 Nov;47(11):902-9
pubmed: 19664756
Compr Psychiatry. 2014 Aug;55(6):1467-72
pubmed: 24850072